Results 231 to 240 of about 110,777 (250)

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

Lancet Infectious Diseases, The, 2021
Matteo Bassetti, Mari Ariyasu, Yohei Doi
exaly  

Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae

Nature Medicine, 2020
Christoph M Ernst, Julian R Braxton, Carlos A Rodriguez-Osorio   +2 more
exaly  

Pervasive transmission of a carbapenem resistance plasmid in the gut microbiota of hospitalized patients

Nature Microbiology, 2021
Ricardo León-Sampedro, Javier DelaFuente, Thomas Crellen   +2 more
exaly  

Regulation and biosynthesis of carbapenem antibiotics in bacteria

Nature Reviews Microbiology, 2005
Sarah J Coulthurst, George P C Salmond
exaly  

Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread

Nature Microbiology, 2019
Sophia David, Sandra Reuter, Corinna Glasner   +2 more
exaly  

The rapid spread of carbapenem-resistant Enterobacteriaceae

Drug Resistance Updates, 2016
Alaric W D'souza, Gautam Dantas
exaly  

Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

Clinical Microbiology Reviews, 2017
Li Yang Hsu, Anucha Apisarnthanarak, Nuntra Suwantarat   +2 more
exaly  

Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study

Lancet Infectious Diseases, The, 2020
David van Duin, Liang Chen, Blake M Hanson   +2 more
exaly